Fortis Malar Hospitals Share Price
Sector: Healthcare Facilities
74.70 +0.31 (0.42%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
74.00
Today’s High
75.88
52 Week Low
51.01
52 Week High
98.70
Key Metrics
- Market Cap (In Cr) 140
- Beta 0.29
- Div. Yield (%) 3.36
- P/B 1.27
- TTM P/E 2.1
- Peg Ratio 0.03
- Sector P/E 22.82
- Open Price 75.88
- Prev Close 74.39
Fortis Malar Hospitals Analysis
Price Analysis
-
1 Week-2.54%
-
3 Months29.55%
-
6 Month39.05%
-
YTD23.12%
-
1 Year6.18%
Risk Meter
- 49% Low risk
- 49% Moderate risk
- 49% Balanced Risk
- 49% High risk
- 49% Extreme risk
Fortis Malar Hospitals News
IHH Healthcare arm increases damages sought from Daiichi Sankyo to ₹11,800 crore
1 min read . 20 May 2025Fortis Malar Hospitals, Aster DM Healthcare, shares to trade ex-dividend today
2 min read . 23 Apr 2024ICICI Securities, Aster DM Healthcare, others to trade ex-dividend next week
1 min read . 20 Apr 2024Fortis Malar Hospitals Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 59.01
- Selling/ General/ Admin Expenses Total
- 15.16
- Depreciation/ Amortization
- 9.36
- Other Operating Expenses Total
- 36.28
- Total Operating Expense
- 22.36
- Operating Income
- 36.65
- Net Income Before Taxes
- 50.01
- Net Income
- 45.32
- Diluted Normalized EPS
- 4.09
- Period
- 2024
- Total Assets
- 115.88
- Total Liabilities
- 6.41
- Total Equity
- 109.47
- Tangible Book Valueper Share Common Eq
- 58.41
- Period
- 2024
- Cashfrom Operating Activities
- -7.3
- Cashfrom Investing Activities
- 119.7
- Cashfrom Financing Activities
- -10.85
- Net Changein Cash
- 101.55
- Period
- 2023
- Total Revenue
- 85.95
- Selling/ General/ Admin Expenses Total
- 50.63
- Depreciation/ Amortization
- 12.15
- Other Operating Expenses Total
- 18.08
- Total Operating Expense
- 93.53
- Operating Income
- -7.58
- Net Income Before Taxes
- -7.01
- Net Income
- -15.48
- Diluted Normalized EPS
- -8.26
- Period
- 2023
- Total Assets
- 138
- Total Liabilities
- 73.83
- Total Equity
- 64.17
- Tangible Book Valueper Share Common Eq
- 34.15
- Period
- 2023
- Cashfrom Operating Activities
- 5.61
- Cashfrom Investing Activities
- 0.5
- Cashfrom Financing Activities
- -12.65
- Net Changein Cash
- -6.54
- Period
- 2022
- Total Revenue
- 86.18
- Selling/ General/ Admin Expenses Total
- 63.08
- Depreciation/ Amortization
- 12.53
- Other Operating Expenses Total
- 0.05
- Total Operating Expense
- 95.27
- Operating Income
- -9.09
- Net Income Before Taxes
- -8.26
- Net Income
- -8.27
- Diluted Normalized EPS
- -4.43
- Period
- 2022
- Total Assets
- 160.91
- Total Liabilities
- 80.78
- Total Equity
- 80.13
- Tangible Book Valueper Share Common Eq
- 42.4
- Period
- 2022
- Cashfrom Operating Activities
- 6.84
- Cashfrom Investing Activities
- 8.23
- Cashfrom Financing Activities
- -10.1
- Net Changein Cash
- 4.98
- Period
- 2021
- Total Revenue
- 69.24
- Selling/ General/ Admin Expenses Total
- 58.82
- Depreciation/ Amortization
- 12.88
- Other Operating Expenses Total
- 0.03
- Total Operating Expense
- 81.61
- Operating Income
- -12.36
- Net Income Before Taxes
- -11.31
- Net Income
- -7.87
- Diluted Normalized EPS
- -6.57
- Period
- 2021
- Total Assets
- 169.1
- Total Liabilities
- 80.35
- Total Equity
- 88.74
- Tangible Book Valueper Share Common Eq
- 46.61
- Period
- 2021
- Cashfrom Operating Activities
- -0.86
- Cashfrom Investing Activities
- -27.51
- Cashfrom Financing Activities
- -7.25
- Net Changein Cash
- -35.62
- Period
- 2020
- Total Revenue
- 111.87
- Selling/ General/ Admin Expenses Total
- 90.13
- Depreciation/ Amortization
- 12.53
- Other Operating Expenses Total
- 0.09
- Total Operating Expense
- 127.1
- Operating Income
- -15.23
- Net Income Before Taxes
- -11.93
- Net Income
- -8.89
- Diluted Normalized EPS
- -4.72
- Period
- 2020
- Total Assets
- 193.55
- Total Liabilities
- 97.14
- Total Equity
- 96.41
- Tangible Book Valueper Share Common Eq
- 49.97
- Period
- 2020
- Cashfrom Operating Activities
- -0.3
- Cashfrom Investing Activities
- 49.88
- Cashfrom Financing Activities
- -11.57
- Net Changein Cash
- 38.01
- Period
- 2019
- Total Revenue
- 144.59
- Selling/ General/ Admin Expenses Total
- 23.46
- Depreciation/ Amortization
- 4.38
- Other Operating Expenses Total
- 90.09
- Total Operating Expense
- 151.33
- Operating Income
- -6.73
- Net Income Before Taxes
- 2.79
- Net Income
- 2.06
- Diluted Normalized EPS
- 1.12
- Period
- 2019
- Total Assets
- 150.85
- Total Liabilities
- 45.48
- Total Equity
- 105.38
- Tangible Book Valueper Share Common Eq
- 55.18
- Period
- 2019
- Cashfrom Operating Activities
- -15.97
- Cashfrom Investing Activities
- 6.34
- Cashfrom Financing Activities
- 0.15
- Net Changein Cash
- -9.48
- Period
- 2024-12-31
- Total Revenue
- 0
- Selling/ General/ Admin Expenses Total
- 0.01
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.4
- Total Operating Expense
- 0.41
- Operating Income
- -0.41
- Net Income Before Taxes
- 0.15
- Net Income
- 0.01
- Diluted Normalized EPS
- 0
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 0
- Selling/ General/ Admin Expenses Total
- 0
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.47
- Total Operating Expense
- 0.47
- Operating Income
- -0.47
- Net Income Before Taxes
- 0.09
- Net Income
- 0.09
- Diluted Normalized EPS
- 0.05
- Period
- 2024-09-30
- Total Assets
- 36.71
- Total Liabilities
- 6.87
- Total Equity
- 29.84
- Tangible Book Valueper Share Common Eq
- 15.92
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 0.7
- Cashfrom Investing Activities
- -28.16
- Cashfrom Financing Activities
- -79.65
- Net Changein Cash
- -107.11
- Period
- 2024-06-30
- Total Revenue
- 0
- Selling/ General/ Admin Expenses Total
- 0.47
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.41
- Total Operating Expense
- 0.88
- Operating Income
- -0.88
- Net Income Before Taxes
- -0.06
- Net Income
- -0.06
- Diluted Normalized EPS
- -0.03
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 5.52
- Selling/ General/ Admin Expenses Total
- -5.85
- Depreciation/ Amortization
- 1.06
- Other Operating Expenses Total
- 9.72
- Total Operating Expense
- -51.83
- Operating Income
- 57.35
- Net Income Before Taxes
- 58.72
- Net Income
- 54.05
- Diluted Normalized EPS
- 0.39
- Period
- 2024-03-31
- Total Assets
- 115.88
- Total Liabilities
- 6.41
- Total Equity
- 109.47
- Tangible Book Valueper Share Common Eq
- 58.41
- Period
- 2024-03-31
- Cashfrom Operating Activities
- -7.3
- Cashfrom Investing Activities
- 119.7
- Cashfrom Financing Activities
- -10.85
- Net Changein Cash
- 101.55
- Period
- 2023-12-31
- Total Revenue
- 17.58
- Selling/ General/ Admin Expenses Total
- 11.07
- Depreciation/ Amortization
- 2.91
- Other Operating Expenses Total
- 4.66
- Total Operating Expense
- 21.58
- Operating Income
- -4
- Net Income Before Taxes
- -4
- Net Income
- -4
- Diluted Normalized EPS
- -2.14
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Fortis Malar Hospitals Technical
Moving Average
SMA
- 5 Day77.35
- 10 Day75.03
- 20 Day76.99
- 50 Day74.11
- 100 Day66.63
- 300 Day62.61
Fortis Malar Hospitals Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Aashka Hospitals
- 96.9
- -0.1
- -0.1
- 126.55
- 65.26
- 226.75
- Lotus Eye Hospital And Institute
- 74.39
- 0.29
- 0.39
- 91
- 53
- 154.7
- Fortis Malar Hospitals
- 74.7
- 0.31
- 0.42
- 98.7
- 51.01
- 140
- Aspira Pathlab & Diagnostics
- 61.6
- 2.9
- 4.94
- 106.78
- 25
- 63.41
- N G Industries
- 164.5
- 6.75
- 4.28
- 205.5
- 145
- 55.11
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Aashka Hospitals
- 96.14
- 2.36
- 2.55
- 5.12
- Lotus Eye Hospital And Institute
- 52.62
- 2.58
- 4.65
- 6.09
- Fortis Malar Hospitals
- 18.31
- 1.28
- 1.1
- 1.17
- Aspira Pathlab & Diagnostics
- -
- 5.67
- -2.56
- -1.64
- N G Industries
- 10.56
- 1.47
- 18.04
- 21.38
Fortis Malar Hospitals Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 15-May-25
- Audited Results
- 03-Feb-25
- Quarterly Results
- 05-Nov-24
- Quarterly Results
- 22-Jul-24
- Quarterly Results
- 17-May-24
- Audited Results
- 12-Apr-24
- Interim Dividend
- 08-Apr-24
- Interim Dividend
- 05-Feb-24
- Quarterly Results
- 06-Nov-23
- Quarterly Results
- 02-Aug-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 13-Jan-25
- 13-Dec-24
- POM
- 31-Jul-24
- 10-Jul-24
- AGM
- 05-Jan-24
- 04-Dec-23
- POM
- 31-Jul-23
- 19-May-23
- AGM
- 27-Jul-22
- 22-Jun-22
- AGM
- 19-Feb-22
- 13-Jan-22
- POM
- 29-Jul-21
- 29-Jun-21
- AGM
- 12-Mar-21
- 08-Feb-21
- POM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 17-May-24
- 24-Jul-24
- 24-Jul-24
- 2.5
- 01-Apr-24
- 23-Apr-24
- 23-Apr-24
- 40


